[SCHEDULE 13G] BioCardia, Inc. SEC Filing

Rhea-AI Filing Summary

Lincoln Alternative Strategies LLC reported beneficial ownership of 800,000 shares of BioCardia, Inc. common stock, representing 7.54% of the outstanding shares based on 10,608,734 shares outstanding as of September 19, 2025. The filing lists sole voting and dispositive power over all 800,000 shares and indicates the holder is organized in Delaware. The filing includes a certification that the securities were not acquired to change or influence control of the issuer. Contact and address details for the issuer and filer are provided in the statement.

Positive

• Transparency: Filing discloses exact share count (800,000) and percentage (7.54%) providing clear ownership transparency
• Sole control: Reporting person states sole voting and dispositive power over all reported shares
• Certification: Statement includes certification that shares were not acquired to influence control of the issuer

Negative

• Sizeable stake: 7.54% is material and could attract market attention despite certification of passive intent

Insights

Securities Analyst

TL;DR A passive disclosure of a sub-10% stake, signalling a noteworthy but non-controlling investment position.

The filing shows Lincoln Alternative Strategies LLC holds 7.54% of BioCardia (800,000 shares) with sole voting and dispositive power, meeting Schedule 13G reporting thresholds for sizeable passive holdings. The certification asserts the stake is not intended to influence control, aligning with a passive investor profile. This is a material disclosure for share ownership transparency but does not indicate strategic control or board influence.

Corporate Governance Expert

TL;DR Ownership disclosure is material for governance transparency but presents no immediate governance change.

The report provides clear identification of the reporting entity, ownership percentage, and voting/dispositive powers. Because the filer certifies no intent to change control and the stake is under typical control thresholds, this filing likely has neutral governance implications. Investors should note the exact share count and the filer’s affirmation for regulatory context.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

BioCardia, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

09060U606

(CUSIP Number)

09/19/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 09060U606

1

Names of Reporting Persons

Lincoln Alternative Strategies LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 800,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 800,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

800,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.54 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Beneficial ownership percentage is based on 10,608,734 shares of the Issuer's common stock issued and outstanding as of September 19, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BioCardia, Inc.
(b)	Address of issuer's principal executive offices: 320 Soquel Way, Sunnyvale, CA, 94085
Item 2.
(a)	Name of person filing: Lincoln Alternative Strategies LLC
(b)	Address or principal business office or, if none, residence: 404 Washington Ave., Suite 650, Miami Beach, FL 33139
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 09060U606
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 800,000
(b)	Percent of class: 7.54%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 800,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 800,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lincoln Alternative Strategies LLC

Signature:	/s/ Stephen Temes
Name/Title:	Stephen Temes/Managing Member
Date:	09/19/2025

FAQ

How many BioCardia (BCDA) shares does Lincoln Alternative Strategies LLC own?

The filer reports ownership of 800,000 shares, representing 7.54% of outstanding common stock.

Does Lincoln Alternative Strategies LLC have voting control over the shares?

Yes. The filing states the filer has sole voting power and sole dispositive power over all 800,000 shares.

Is this stake intended to change control of BioCardia (BCDA)?

The filing includes a certification that the securities were not acquired to change or influence control of the issuer.

What date is the ownership based on?

The reported ownership and outstanding share count are stated as of September 19, 2025.

Who filed the Schedule 13G for BCDA?

The filing was made by Lincoln Alternative Strategies LLC, a Delaware limited liability company.